Search

Your search keyword '"Zemfira A. Bredikhina"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Zemfira A. Bredikhina" Remove constraint Author: "Zemfira A. Bredikhina" Topic chemistry Remove constraint Topic: chemistry
95 results on '"Zemfira A. Bredikhina"'

Search Results

1. Chirality-dependent supramolecular synthons based on the 1,3-oxazolidin-2-one framework: chiral drugs mephenoxalone, metaxalone and 114 other examples

2. Nonracemic Dimethylphenyl Glycerol Ethers in the Synthesis of Physiologically Active Aminopropanols

3. Stereoselective Crystallization of Chiral 3,4-Dimethylphenyl Glycerol Ether Complicated by Plurality of Crystalline Modifications

4. Synthesis, phase behavior and absolute configuration of β-adrenoblocker bupranolol and related compounds

5. Crystallization of Chiral para-n-Alkylphenyl Glycerol Ethers: Phase Diversity and Impressive Predominance of Homochiral Guaifenesin-Like Supramolecular Motif

6. Synthesis, crystal structure, and absolute configuration of the enantiomers of chiral drug xibenolol hydrochloride

7. Crystallization features and spontaneous resolution of 3-(2,6-dimethoxyphenoxy)propane-1,2-diol: The case of stable conglomerate and metastable solid solution

8. Spontaneous Resolution of Chiral 3-(2,3-Dimethylphenoxy)propane-1,2-diol under the Circumstances of an Unusual Diversity of Racemic Crystalline Modifications

9. Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production

10. Synthesis and crystal structure of ( S )-pindolol

11. Chirality, Gelation Ability and Crystal Structure: Together or Apart? Alkyl Phenyl Ethers of Glycerol as Simple LMWGs

12. Intricate Phase Behavior and Crystal Structure Features of Chiral para-Methoxyphenyl Glycerol Ether Forming Continuous and Partial Solid Solutions

13. Comparative analysis of the binding of thiacalix[4]arene-monocrown-ethers with monovalent metal salts using MALDI mass spectrometry

14. New example of spontaneous resolution among aryl glycerol ethers: 3-(2,6-dichlorophenoxy)propane-1,2-diol

15. Synthesis of all of the stereoisomers of β3-adrenoceptor antagonist SR 59230 based on the spontaneous resolution of 3-(2-ethylphenoxy)propane-1,2-diol

16. The effective direct resolution procedure for the chiral drug bevantolol hydrochloride

17. Effective synthesis of non-racemic prenalterol based on spontaneous resolution of 3-(4-hydroxyphenoxy)propane-1,2-diol

18. Chiral (2-cyanophenoxy)methyl-15-crown-5 in diastereomeric discrimination of amino acid esters according to the data of electrospray ionization mass spectrometry

19. From racemic epichlorohydrin to a single enantiomer of the drug timolol maleate

20. Stereoselective crystallization of 3-(2,6-dimethylphenoxy)propane-1,2-diol: preparation of the single-enantiomer drug mexiletine

21. Conglomerate formative precursor of chiral drug timolol: 3-(4-Morpholino-1,2,5-thiadiazol-3-yloxy)-propane-1,2-diol

22. 4-Benzoylamino-3-hydroxybutyric Acid, Historically First 'Anomalous Racemate': Reinvestigation

23. Synthesis and some features of phase behavior of chiral p-alkoxyphenyl glycerol ethers

24. Comparative analysis of interactions of some lariat crown ethers and their unsubstituted analogues with alkali metal salts in the gas phase by MALDI mass spectrometry

25. Lariat ethers in the chiral recognition of amino acid esters:electrospray ionization mass spectrometry investigation

26. Synthesis of enantiomerically pure 3-aryloxy-2-hydroxypropanoic acids, intermediate products in the synthesis of cis-4-Aminochroman-3-ols

27. Mass spectrometric investigation of the side-arm lariat effect of ortho- and para-methoxyphenoxymethyl-15-crown-5 in the gas phase

28. Phase behavior and crystal structure of 3-(1-naphthyloxy)- and 3-(4-indolyloxy)-propane-1,2-diol, synthetic precursors of chiral drugs propranolol and pindolol

29. Chiral para-alkyl phenyl ethers of glycerol: synthesis and testing of chirality driven crystallization, liquid crystal, and gelating properties

30. Crystallographic evidence of side-arm lariat effect in the series of chiral ortho- and para-methoxyphenoxymethyl-15-crown-5 complexes with sodium perchlorate

31. Crystallization of chiral compounds: thermodynamical, structural and practical aspects

32. Chiral drugtimolol maleate as a continuous solid solution: Thermochemical and single crystal X-ray evidence

33. Crystal structure and phase behavior of the tolyl glycerol ethers. From the conglomerate former to the chirality-driven nanogelator

34. Synthesis and extraction properties of some lariat ethers derived from the spontaneously resolved guaifenesin, 3-(2-methoxyphenoxy)propane-1,2-diol

36. Synthesis and solid state properties of the 4-naphthyloxymethyl-2,2-dioxo-1,3,2-dioxathiolane, cyclic sulfate not available through sulfite oxidation procedure

37. Chirality driven crystallization behavior of ortho, meta, and para-cyanophenyl glycerol ethers

38. Absolute configuration and crystal packing chirality for three conglomerate-forming ortho-halogen substituted phenyl glycerol ethers

39. One more chiral drug prone to spontaneous resolution: Binary phase diagram, absolute configuration, and crystal packing of bevantolol hydrochloride

40. From racemic compounds through metastable to stable racemic conglomerates: crystallization features of chiral halogen and cyano monosubstituted phenyl glycerol ethers

41. Absolute configuration and crystal packing for three chiral drugs prone to spontaneous resolution: Guaifenesin, methocarbamol and mephenesin

42. Spontaneous resolution amongst chiral ortho-cyanophenyl glycerol derivatives: an effective preferential crystallization approach to a single enantiomer of the β-adrenoblocker bunitrolol

43. Spontaneous resolution among chiral glycerol derivatives: crystallization features of ortho-alkoxysubstituted phenyl glycerol ethers

44. Chiral drugs related to guaifenesin: synthesis and phase properties of methocarbamol and mephenoxalone

45. Solid state properties and effective resolution procedure for guaifenesin, 3-(2-methoxyphenoxy)-1,2-propanediol

46. Stereochemistry of 1,3-diheterocyclanes 4. Molecular and crystal structures of monosubstituted five-membered cyclic sulfites

47. Crystallization of chiral compounds 3. 3-phenoxypropane-1,2-diol and 3-(2-halophenoxy)propane-1,2-diols

48. Solid state properties of 1,2-epoxy-3-(2-methoxyphenyloxy)-propane—valuable intermediate in non-racemic drug synthesis

49. Electroreduction of Phthalazines and 1,2,5-Thiadiazoles: Structural Factors Determining the Opening of Heterocycle

50. Stereochemistry of 1,3-Diheterocyclanes: III. Crystal and Molecular Structure and Conformations of cis- and trans-5-Phenoxy-1,3,2-dioxathiane 2-Oxides

Catalog

Books, media, physical & digital resources